C H ROBINSON WORLDWI (CHRW) is drawing unusual attention today. Our newswire has captured 5 stories on CHRW across 3 sources in the last 36 hours, with AI sentiment reading mixed (avg 55/100).
CHRW stock is down 6.85% at $191.44 as of the latest trade. The decline follows a significant gap down at the open and a sharp intraday selloff. The stock opened at $201.30, a 2.0% drop from the previous close, and fell to a session low of $188.00 before recovering slightly. The move appears to be driven by investor reaction to a recent SEC 8-K filing by the company, which disclosed a Regulation FD item.
C. H. Robinson Worldwide filed an 8-K on July 24, 2026, indicating a disclosure under Regulation FD. The filing does not specify the nature of the information but may have triggered investor uncertainty. The stock’s sharp decline came despite recent analyst activity, including new coverage from Citizens and upgrades from Stifel, Truist, and Susquehanna, all of which maintain Buy or positive ratings with price targets above the current price. However, the market appears to be discounting this optimism in light of the recent filing.
The stock is trading within a 52-week range of $96.89 to $210.33 and has a trailing twelve-month revenue decline of 6.7%. The P/E ratio is 41.6, and the stock has a beta of 0.91, indicating slightly less volatility than the broader market. The session volume of 0.3 million shares is 0.2 times the 3-month average, suggesting relatively light participation. The stock has also seen recent congressional activity, with Rep. April McClain Delaney making three purchases in the $1,001, $15,000 range between May 21 and May 28.
Investors should monitor the company’s next earnings report for further clarity. No earnings date is currently provided, but coverage breadth and any follow-up disclosures from the company will be key to understanding the trajectory of the stock.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
CHRW Q2 2026 earnings call insights: freight-cycle margins, Lean AI productivity, spot-rate outlook, capital returns and Texas verdict risks.
Thomas Wadewitz - UBS Investment Bank, Research Division Jeffrey Kauffman - Citizens JMP Securities, LLC, Research Division Ken Hoexter - BofA Securities, Research Division Bascome Majors - Stephens Inc., Research Division Scott Group - Wolfe Research, LLC Jonathan Chappell - Evercore ISI Institutional Equities, Research Division Stephanie Benjamin Moore - Jefferies LLC, Research Division Richa Talwar - Deutsche Bank AG, Research Division
Filed: 2026-07-29 AccNo: 0001043277-26-000027 Size: 5 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
CHRW Q2 earnings: Non-GAAP EPS beats and revenue surges 19% YoY.
C H ROBINSON WORLDWI (CHRW) is drawing unusual attention today. Our newswire has captured 5 stories on CHRW across 3 sources in the last 36 hours, with AI sentiment reading mixed (avg 55/100). The most recent driver: "C.H. Robinson forecasts 2026 capex of $65M-$75M amid supply-driven tightening and ongoing legal appeal process" (Seeking Alpha).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of CHRW coverage reads 55/100 over 5 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on CHRW: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CHRW move explainers: 2026-07-24